mitoxantrone has been researched along with Refractory Anemia in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ngirabacu, MC | 1 |
| Ravoet, C | 1 |
| Dargent, JL | 1 |
| Meuleman, N | 1 |
| Ahmad, I | 1 |
| Ysebrant, L | 1 |
| Bennani, J | 1 |
| André, M | 1 |
| Bron, D | 1 |
1 other study available for mitoxantrone and Refractory Anemia
| Article | Year |
|---|---|
Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis.
Topics: Acute Disease; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 2006 |